These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 16122803

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry.
    Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF.
    J Immunol; 1998 Jun 15; 160(12):5898-906. PubMed ID: 9637502
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A, Calcaterra C, Mènard S, Balsari A.
    J Leukoc Biol; 2007 Sep 15; 82(3):509-18. PubMed ID: 17586660
    [Abstract] [Full Text] [Related]

  • 8. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
    Wang L, Jiang W, Ding G, Cao H, Lu Y, Luo P, Zhou H, Zheng J.
    Int Immunopharmacol; 2007 May 15; 7(5):646-55. PubMed ID: 17386412
    [Abstract] [Full Text] [Related]

  • 9. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
    Sen G, Flora M, Chattopadhyay G, Klinman DM, Lees A, Mond JJ, Snapper CM.
    Cell Immunol; 2004 May 15; 232(1-2):64-74. PubMed ID: 15922717
    [Abstract] [Full Text] [Related]

  • 10. CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumor.
    Yuan S, Qiao T, Chen W.
    Cancer Biother Radiopharm; 2011 Apr 15; 26(2):203-8. PubMed ID: 21539452
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides.
    Paget C, Bialecki E, Fontaine J, Vendeville C, Mallevaey T, Faveeuw C, Trottein F.
    J Immunol; 2009 Feb 15; 182(4):1846-53. PubMed ID: 19201836
    [Abstract] [Full Text] [Related]

  • 13. CpG oligodeoxynucleotide-induced immunity prevents growth of germinal center-derived B lymphoma cells.
    Ponzio NM, Cutro S, Hu J, Marzouk A, Marshall JD.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):2057-68. PubMed ID: 17161362
    [Abstract] [Full Text] [Related]

  • 14. CpG oligodeoxynucleotides directly induce CXCR3 chemokines in human B cells.
    Kato A, Ogasawara T, Homma T, Batchelor J, Imai S, Wakiguchi H, Saito H, Matsumoto K.
    Biochem Biophys Res Commun; 2004 Aug 06; 320(4):1139-47. PubMed ID: 15249208
    [Abstract] [Full Text] [Related]

  • 15. CpG ODN enhances immunization effects of hepatitis B vaccine in aged mice.
    Qin W, Jiang J, Chen Q, Yang N, Wang Y, Wei X, Ou R.
    Cell Mol Immunol; 2004 Apr 06; 1(2):148-52. PubMed ID: 16212903
    [Abstract] [Full Text] [Related]

  • 16. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction.
    Bleich A, Janus LM, Smoczek A, Westendorf AM, Strauch U, Mähler M, Hedrich HJ, Fichtner-Feigl S, Schölmerich J, Falk W, Hofmann C, Obermeier F.
    Gastroenterology; 2009 Jan 06; 136(1):278-87. PubMed ID: 18952084
    [Abstract] [Full Text] [Related]

  • 17. CpG oligodeoxynucleotide prolongs eosinophil survival through activation of contaminating B cells and plasmacytoid dendritic cells in vitro.
    Matsumoto K, Terakawa M, Fukuda S, Kato A, Toki S, Shinohara M, Wakiguchi H, Saito H.
    Int Arch Allergy Immunol; 2006 Jan 06; 140 Suppl 1():42-50. PubMed ID: 16772726
    [Abstract] [Full Text] [Related]

  • 18. Identification of cytosine-phosphorothioate-guanine oligodeoxynucleotide sequences that induce interferon-γ production in feline immune cells.
    Satoh R, Kotake M, Takano T, Motokawa K, Gemma T, Watanabe R, Arai S, Hohdatsu T.
    Microbiol Immunol; 2011 Mar 06; 55(3):184-90. PubMed ID: 21204950
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors.
    El Andaloussi A, Sonabend AM, Han Y, Lesniak MS.
    Glia; 2006 Nov 01; 54(6):526-35. PubMed ID: 16906541
    [Abstract] [Full Text] [Related]

  • 20. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR, Zhu F, Li Y, Bhagat L, Cong Y, Kandimalla ER, Agrawal S.
    Nucleic Acids Res; 2006 Nov 01; 34(11):3231-8. PubMed ID: 16798912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.